Characterization of nuclear oxalate binding protein of rat and human kidney
1Department of Medical Biochemistry, University of Madras, Taramani, India.
Purpose:
To characterize the nuclear oxalate binding protein and its involvement in hyperoxaluria.
Materials And Methods:
Rat and human renal cortical epithelial cell nuclear protein was isolated and studied. Renal nuclear histones were isolated by acid extraction and purified by ion exchange column chromatography.
Results:
Most of the 14C-oxalate binding was present in the histone-H1 fraction. The oxalate binding activity resided exclusively in the H1B fraction of H1. The protein was purified 13 to 16-fold with a specific activity of 940 to 1570 pmol./mg. protein. Oxalate binding to rat or human kidney or calf thymus histone was rapid, reversible, pH dependent and saturable. Trypsin treatment abolished the binding activity. Scatchard plot analysis revealed the presence of 2 distinct oxalate binding sites, one with high affinity and the other with low affinity. Oxalate binding was inhibited by DIDS (4,4'-diisothio-cyanostilbene-2, 2'-disulfonic acid) and other dicarboxylate transport inhibitors. The IC50 values for different substrate analogues were, in decreasing order, oxalate < oxamate < succinate < glyoxylate < malate < glycolate. In experimental urolithic rats, histone oxalate binding was increased by 50 to 70%. The higher oxalate binding activity in hyperoxaluric rats was due to increased formation of H1. Histone exhibited in vitro calcium oxalate crystal growth promoter activity.
Conclusion:
Oxalate binding activity resided in the H1B of histone H1. The protein promoted calcium oxalate crystal growth. This suggested a possible role for this protein in the retention of calcium oxalate in the nucleus.
Related Concept Videos
Drug Distribution: Plasma Protein Binding
Protein-Drug Binding: Mechanism and Kinetics
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Factors Affecting Protein-Drug Binding: Drug-Related Factors
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In contrast,...
Factors Affecting Protein-Drug Binding: Protein-Related Factors
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be bound by...
Renal Drug Excretion: Tubular Secretion
Physiological Pharmacokinetic Models: Assumption with Protein Binding


